In vitro and in vivo chromosomal aberrations induced by megazol

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 560, Issue 2, 2004, Pages 147-158

  Nesslany, Fabrice ^a   Brugier, Serge ^b   Mouriès, Marie Annick ^c   Le Curieux, Frank ^a,d   Marzin, Daniel ^a,d  

^a INSTITUT PASTEUR DE LILLE   (France)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

^c WORLD BANK   (United States)

^d UNIV LILLE   (France)

Author keywords

In vitro chromosomal aberrations; In vivo chromosomal aberrations; Megazol; Nitroimidazole; Trypanosomoses

Indexed keywords

2 AMINO 5 (1 METHYL 5 NITRO 2 IMIDAZOLYL) 1,3,4 THIADIAZOLE; ANTITRYPANOSOMAL AGENT;

AFRICAN TRYPANOSOMIASIS; ANIMAL CELL; ARTICLE; BONE MARROW; CHAGAS DISEASE; CHROMOSOME ABERRATION; CONTROLLED STUDY; GENOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOMA CELL LINE; METAPHASE; MICRONUCLEUS TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BIOTRANSFORMATION; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; MALE; MICE; MUTAGENS; RATS; RATS, SPRAGUE-DAWLEY; THIADIAZOLES; TRYPANOCIDAL AGENTS;

EID: 2442472289     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2004.02.013     Document Type: Article

References (32)

1. Bouteille B., Marie-Daragon A., Chauvière G., de Albuquerque C., Enanga B., Darde J.-M., Perie J., Dumas M. Effect of megazol on Trypanosoma brucei brucei acute and subacute infections in Swiss mice. Acta Tropica. 60:1995;73-80
2. S. Van Nieuwenhove, Present strategies in the treatment of human African trypanosomiasis, in: M. Dumas, B. Bouteille, A. Buguet (Eds.), Progress in HAT Sleeping Sickness, Springer-Verlag, 1999, France (Chapter 15).
3. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect. Dis. 1:2001;92-100
4. Berkelhammer G., Asato G. 2-Amino-5-(1-methyl-5-nitro-2-imidazolyl)-1, 3, 4-thiadiazole: a new antimicrobial agent. Science. 162:1968;1146
5. Ferreira R.C.C., Ferreira L.C.S. Mutagenicity of CL 64855, a potent anti-trypanosoma cruzi drug. Mutat. Res. 171:1986;11-15
6. Dobias L., Cerna M., Rossner P., Sram R. Genotoxicity and carcinogenicity of metronidazole. Mutat. Res. 317:1994;177-194
7. Poli P., de Mello M.A., Buschini A., Mortara R.A., de Albuquerque C.N., da Silva S., Rossi C., Zucchi T.M.A.D. Cytotoxic and genotoxic effects of megazol, an anti-Chagas' disease drug, assessed by different short-term tests. Biochem. Pharmacol. 64:2002;1617-1627
8. de Morais M.A., Ferreira R.C.C., Ferreira L.C.S. Mutagenic activation of CL 64 855, an anti-Trypanosoma cruzi nitroderivant, by bacterial nitroreductases. Genet. Mol. Biol. 21:1998;567-572
9. Moreira da Silva, P. de C. Alm, B. Gilbert, A.M. Ferreira Filho, M.E.A. Gilbert, C.S. Monteiro da Silva, Final Report to National Research Council, Brazil, PIDE Programme, Project 2222.8-133/80, December 1981.
10. Ames B.N., Mc Cann J., Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/Mammalian-microsome mutagenicity test. Mutat. Res. 31:1975;347-364
11. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113:1983;173-215
12. Nesslany F., Marzin D. A micromethod for the in vitro micronucleus assay. Mutagenesis. 14:1999;403-410
13. Fenech M., Chang W.P., Kirsch-Volders M., Holland N., Bonassi S., Zeiger E. HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat. Res. 534:2003;45-64
14. Borenfreud E., Babich H., Martin-Alguacil N. Comparison of two in vitro cytotoxicity assays: the neutral red (NR) and tetrazolium MTT tests. Toxicol. In Vitro. 2:1988;1-6
15. EC - Commission Directive 2000/32/EC - B.10, Mutagenicity: In Vitro Cytogenetic Assay on Mammalian - EC Official J. L136 8/6/2000.
16. OECD - Guideline for the Testing of Chemicals, No. 473: In Vitro Mammalian Chromosome Aberration Test, 21 July 1997.
17. Savage J.R.K. Classification and relationship of induced chromosomal structural changes. J. Med. Genet. 12:1975;103-122
18. EC - Commission Directive 2000/32/EC - B.12, Mutagenicity: Mammalian Erythrocyte Micronucleus Test - EC Official J. L 136 8/6/2000.
19. OECD - Guideline for the Testing of Chemicals No. 474: Mammalian Erythrocyte Micronucleus Test, 21 July 1997.
20. Hayashi M., Tice R.R., MacGREGOR J.T. Report of the International Workshop on standardization of genotoxicity test procedures: in vivo rodent erythrocyte micronucleus assay, in: Sixth ICEM, Melbourne, 1993. Mutat. Res. 312:1994;293-304
21. Schmid W. The micronucleus test. Mutat. Res. 31:1975;9-15
22. Voogd C.E., Van der Stel J.J., Jacobs J.J.J.A.A. The mutagenic action of nitroimidazoles. Mutat. Res. 66:1979;207-221
23. Belisario M.A., de Lorenzo F., de Marinis E. Activation in vivo of 5-nitroimidazoles. Mutat. Res. 97:1982;171
24. Roe F.J.C. Safety of nitroimidazoles. Scand. J. Infect. Dis. 46:1985;72-81
25. Rozenkranz H.S., Speck W.T., Stambaugh J.E. Mutagenicity of metronidazole: structure activity relationships. Mutat. Res. 38:1976;203-206
26. Dayan J., Deguingand S., Truzman C., Chevron M. Application of the SOS chromotest to 10 pharmaceutical agents. Mutat. Res. 187:1997;55-66
27. Suter W., Jaeger I. Comparative evaluation of different pairs of DNA repairs-deficient and DNA repair-proficient bacterial tester strains for rapid detection of chemical mutagens and carcinogens. Mutat. Res. 97:1982;1-18
28. Knassmüller S., Kerklaan P., Mohn G.R. Use of DNA-repair host-mediated assay for determining the organ distribution of genotoxic factors in mice treated orally with nitro-aromatic compounds. Mutat. Res. 164:1986;9-17
29. Rithidech K., Harper B.L., Ward J.B., Legator M.S. Cytogenetic effect of metronidazole and its metabolites on G2-phase human lymphocytes. Environ. Mutagen. 6:1984;467-468
30. F. Mitelman, B. Hartley-Asp, B. Ursing, Chromosome aberrations and metronidazole, Lancet 2 (7989) (1976) 802.
31. Garry V.F., Nelson R.L. Host-mediated transformation: metronidazole. Mutat. Res. 190:1987;289-295
32. Rustia M., Shubik P. Experimental induction of hepatomas, mammary tumors, and other tumors with metronidazole in noninbred Sas: MRC(WI)BR rats. JNCI. 63:1979;863-867